Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Steroids in multiple sclerosis

T D Griffiths¹, P K Newman

¹Department of Neurology, Middlesbrough General Hospital, Cleveland, U.K.

Journal of Clinical Pharmacy and Therapeutics

|August 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brain Charts for the Rhesus Macaque Lifespan.

bioRxiv : the preprint server for biology·2024

Same author

Evidence for causal top-down frontal contributions to predictive processes in speech perception.

Nature communications·2017

Same author

Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.

Journal of neurology, neurosurgery, and psychiatry·2014

Same author

Resource allocation and prioritization in auditory working memory.

Cognitive neuroscience·2013

Same author

Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes.

Neuropathology and applied neurobiology·2011

Same author

On the Pathology and Treatment of Intestinal Wounds.

British medical journal·2010

Same journal

Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.

Journal of clinical pharmacy and therapeutics·2022

Same journal

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.

Journal of clinical pharmacy and therapeutics·2022

Same journal

The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.

Journal of clinical pharmacy and therapeutics·2022

Same journal

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.

Journal of clinical pharmacy and therapeutics·2022

See all related articles

Short courses of high-dose steroids, specifically methylprednisolone, are effective for multiple sclerosis relapses. This treatment accelerates recovery and has a proven safety profile for short-term use.

Area of Science:

Neurology
Immunology

Background:

Multiple sclerosis (MS) relapses are frequently treated with steroids.
Long-term steroid therapy is not recommended for managing MS.

Purpose of the Study:

To evaluate the efficacy and safety of short-term, high-dose methylprednisolone for multiple sclerosis relapses.

Main Methods:

Review of current clinical practice for MS relapse management.
Analysis of data on methylprednisolone treatment protocols.

Main Results:

High-dose methylprednisolone courses accelerate recovery from MS relapses.
This short-term steroid regimen demonstrates proven safety.

Conclusions:

Related Experiment Videos

Short-term, high-dose methylprednisolone is the current standard for treating MS relapses.
Repeated short courses are permissible after an interval, maintaining safety and efficacy.